Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Article Title: Fully human monoclonal antibody targeting activated ADAM10 on colorectal cancer cells

doi: 10.1016/j.biopha.2023.114494

Figure Lengend Snippet: 1H5 inhibits Notch cleavage. Sandwich ELISA was used to measure the levels of total (A) and cleaved (B) Notch1 in COLO205 cells upon treatment with 1H5. The data represent mean of triplicate experiments, and the bar plots show the effect of treatment with 1H5 relative to untreated control, mean ± SEM. Comparison of notch levels between treated and untreated groups was performed using independent t test. Total Notch1 levels did not significantly differ between the two groups (A), p = 0.162. On the other hand, the mAb-treated group showed significant decrease of the cleaved Notch1 levels when compared with the untreated control (B), p < 0.001.

Article Snippet: To detect NICD1, we used PathScan ® cleaved Notch1 (Val1744) sandwich ELISA Kit (Cell Signaling Technologies).

Techniques: Sandwich ELISA, Control, Comparison

Journal: The Journal of cell biology

Article Title: Aberrant phosphorylation inactivates Numb in breast cancer causing expansion of the stem cell pool.

doi: 10.1083/jcb.202112001

Figure Lengend Snippet: Figure 3. Characterization of Numb phosphomutants. (A) Scheme showing the behavior of a SC (A) and daughter progenitor cell (B) in WT vs. Numb-KO (Tosoni et al., 2015). (B) Scheme of the growth of MS from WT and Numb-KO MECs (Tosoni et al., 2015). (C and D) WT and Numb-KO cells, transduced with the indicated constructs (DsRed fusion proteins; EV, empty vector), were assessed for SFE (C, by counting only red cells or MS) and size (D, N = number of epifluorescent MS analyzed). Results are expressed relative to WT cells (see also Table S2). Significance was calculated vs. EV cells. Representative images of the MS are in D, top panel. Bar, 100 µm. (E) WT and Numb-KO MS, transduced with the indicated constructs (Flag-tagged), were analyzed by IB. Arrows, endogenous (black) or overexpressed (red) Numb (also in G). Activated Notch (Act. Notch) was detected with the anti Val1744 Ab (in this and all subsequent figures). Right: Quantitation of three independent experiments. (F) HEK-293 cells, transfected as indicated (all Numb constructs were Flag-tagged and also codify for an sh-RNA sequence against endogenous Numb; EV, empty vector), were IP and IB as shown. (G) HEK-293 cells were stably transduced with Notch- NΔE (Notch-TFX; NT, not transfected) and transfected with the indicated Numb-Flag constructs (as in F). IP and IB were as shown. (H and I) MCF-7 or Cal51 cells were either transduced with Notch-NΔE (Notch-TFX; I) or not (H). Cells were treated with BIS (or mock-treated) and IP and IB as shown. In H, IP-Ctr is anti-Flag; in I, IP-Ctr is goat IgG. Data are reported ± SD (C and E) or ± SE (D). Statistical analysis was with the Student’s t test two-tailed (C and D) or with the one-sample t test (E). Source data are available for this figure: SourceData F3.

Article Snippet: Ab for immunoblot (IB) were directed against Numb (AB21, a mouse monoclonal Ab against amino acids 537–551 of hNumb [Colaluca et al., 2008]), and for the experiment in Fig. S3 B, the anti-Numb C29G11, rabbit monoclonal from Cell Signaling Technologies (Cat. 4140) was used; Vinculin (mouse monoclonal; Sigma-Aldrich, Cat. V9131); GRP94 (9G10, rat monoclonal, Cat. ADI-SPA-851; Enzo Life Sciences); Tubulin (11H10, rabbit monoclonal, Cat. 2125; Cell Signaling Technologies); p53 (1C12, mouse monoclonal, Cat. 2524; Cell Signaling Technologies, Figs. 3 E, 5, A–C, and 9 D; FL393, Santa Cruz Biotechnology, goat polyclonal, Cat. sc-6243-G, Fig. 3 F; goat polyclonal, Bio-techne, Cat. AF1355 Fig. 3 H); PKCζ (C24E6, rabbit monoclonal, Cat. 9368; Cell Signaling Technologies); p-PKCζ (H-2, mouse monoclonal, Cat. sc-271962; Santa Cruz Biotechnology); PAN-PKC (A-9, mouse monoclonal, Cat. sc-17804; Santa Cruz Biotechnology); pPAN PKC (rabbit polyclonal, Cat. 9371; Cell Signaling Technologies); Notch (5B5, rat monoclonal, Cat. 3447; Cell Signaling Technologies); Cleaved Notch1 Val1744 (D3B8, rabbit monoclonal, Cat. 4147; Cell Signaling Technologies); Flag (D6W5B, rabbit monoclonal, Cat. 2368; Cell Signaling Technologies); Par3 (Cat. 07-330; Millipore); Mdm2 (Mouse Monoclonal, Cat. Op46; Calbiochem); anti GAPDH (rabbit monoclonal, Cat. 5174; Cell Signaling Technologies); and pNumb-Ser276 (rabbit monoclonal, Cat. 4140; Cell Signaling Technologies).

Techniques: Transduction, Construct, Plasmid Preparation, Quantitation Assay, Transfection, Sequencing, Stable Transfection, Two Tailed Test

Journal: Signal Transduction and Targeted Therapy

Article Title: USP7 deubiquitinates and stabilizes NOTCH1 in T-cell acute lymphoblastic leukemia

doi: 10.1038/s41392-018-0028-3

Figure Lengend Snippet: USP7 interacts with ICN1. a HEK293T cells were transfected with plasmids encoding FLAG-tagged USP7 and/or Myc-tagged ICN1. Cell extracts were prepared and immunoprecipitated with anti-FLAG or anti-Myc antibodies. The protein interactions were analyzed by western blotting. b Whole-cell lysates from JURKAT and MOLT-4 cells were subjected to immunoprecipitation with a control IgG or an anti-ICN1 antibody. The immunoprecipitates were detected by western blotting. The input represented ~5% of the total protein extract used for immunoprecipitation. c The direct interaction between USP7 and ICN1 was detected using a GST pull-down assay, and the indicated proteins were examined by western blotting. d USP7 was co-localized with NOTCH1. CUTLL1 cells were fixed and immunostained with anti-USP7 (green) and anti-NOTCH1 (red) antibodies. The cell nuclei were counterstained with DAPI (blue). e Mapping of the ICN1-interacting domain in the USP7 protein. Top panel, a schematic representation of various USP7 truncated mutants. Bottom panel, HEK293T cells were co-transfected with constructs encoding FLAG-tagged ICN1 and GFP-tagged USP7 or truncated mutants. FLAG-tagged ICN1 proteins were immunoprecipitated with an anti-FLAG antibody, and the presence of USP7 protein and truncated mutants was examined by western blotting using an anti-GFP antibody

Article Snippet: The following antibodies were used in this study: anti-cleaved NOTCH1 (Val1744) and anti-β-Actin (CST, Danves, MA, USA); anti-USP7 (Bethyl Laboratories, Montgomery, TX, USA); anti-NOTCH1 and anti-GFP (Santa Cruz, Dallas, TX, USA); anti-HA and anti-Myc epitope tag (MBL, Nagoya, Japan); anti-FLAG (M2) (Sigma-Aldrich, Louis, MO, USA); and anti-HRP-conjugated secondary antibody (Millipore, Bedford, MA, USA).

Techniques: Transfection, Immunoprecipitation, Western Blot, Pull Down Assay, Construct

Journal: Signal Transduction and Targeted Therapy

Article Title: USP7 deubiquitinates and stabilizes NOTCH1 in T-cell acute lymphoblastic leukemia

doi: 10.1038/s41392-018-0028-3

Figure Lengend Snippet: USP7 is overexpressed in T-ALL. a USP7 microarray gene expression data were obtained from the Cancer Cell Line Encyclopedia (CCLE). The data are presented with box plots. The sample number ( n ) are indicated in parentheses. RMA represents Robust Multi-array Average. b Analysis of TCGA leukemia dataset from the Oncomine database to assess the expression of USP7 in normal bone marrow or peripheral blood cells and in T-ALL patient samples. The data are presented with box plots. Fold change, p- value (determined by Student’s t -test), and sample size are shown. c Comparison of USP7 gene expression levels between NOTCH1 WT ( n = 31) and NOTCH1 mutated ( n = 87) T-ALL cases. The read counts mapped to the USP7 transcript were normalized and applied with variance-stabilizing transformation. The p- value was determined using Student’s t -test. Dots represent the value of the USP7 expression level in each of the T-ALL cases. The mean and 25th and 75th percentiles are represented by the midline and line edges in the plots, respectively. d western blotting analysis of the USP7 protein levels in normal PBMCs and T-ALL patient samples (top panel) along with various T-ALL cell lines (bottom panel)

Article Snippet: The following antibodies were used in this study: anti-cleaved NOTCH1 (Val1744) and anti-β-Actin (CST, Danves, MA, USA); anti-USP7 (Bethyl Laboratories, Montgomery, TX, USA); anti-NOTCH1 and anti-GFP (Santa Cruz, Dallas, TX, USA); anti-HA and anti-Myc epitope tag (MBL, Nagoya, Japan); anti-FLAG (M2) (Sigma-Aldrich, Louis, MO, USA); and anti-HRP-conjugated secondary antibody (Millipore, Bedford, MA, USA).

Techniques: Microarray, Expressing, Transformation Assay, Western Blot

Journal: BMC Genomics

Article Title: The periodontal pathogen Porphyromonas gingivalis changes the gene expression in vascular smooth muscle cells involving the TGFbeta/Notch signalling pathway and increased cell proliferation

doi: 10.1186/1471-2164-14-770

Figure Lengend Snippet: The expression of selected genes and proteins in AoSMCs stimulated with P. gingivalis . Quantitative real-time PCR results demonstrate relative transcription for TGF-β1 (A) , CTGF (B) , SMAD3 (C) , NOTCH1 (D) , and HEY1 (E) of AoSMCs stimulated ( P. g ) or unstimulated (control) with P. gingivalis at 10 MOI for 24 h. All these results were normalized by the gene expression level of the house-keeping gene GAPDH. Representative western blot showing NOTCH1 protein expression levels of AoSMCs exposed to P. gingivalis at 8 and 10 MOI (F) . Quantification of NOTCH1 protein expression levels by densitometry is shown in (G) . NOTCH1 density signals were normalized to GAPDH signal values. P. gingivalis resulted in a dose-dependent (MOI 8 and 10) induction of TGF-β1 protein expression (H) . *, p < 0.05; **, p < 0.005; ***, p < 0.0001. A , n = 10; B - E , n = 6; F , G , n = 3; H , n = 3-4.

Article Snippet: After blocking in non-fat dried milk, membranes were probed overnight at 4°C using rabbit polyclonal anti-cleaved Notch1 (Novus Biologicals, Cambridge, UK) in 1: 2,000 dilution.

Techniques: Expressing, Real-time Polymerase Chain Reaction, Control, Gene Expression, Western Blot

Journal: International Journal of Molecular Sciences

Article Title: Indoxyl Sulfate Inhibits Osteogenesis in Bone Marrow Mesenchymal Stem Cells through the AhR/Hes1 Pathway

doi: 10.3390/ijms25168770

Figure Lengend Snippet: IS upregulated the expression of hairy/enhancer of split-1 ( Hes1 ) through AhR. ( A ) qRT-PCR revealed the mRNA levels of Notch receptors and Hes1 in D1 cells treated with IS for at least 4 and 8 h or left untreated. ( B ) Western blotting revealed the protein levels of cleaved-Notch1 and Hes1 in D1 cells treated with IS or a vehicle control for 1 and 2 days. ( C ) qRT-PCR indicated the level of Hes1 expression in control or IS-treated D1 cells subjected to AhR antagonist (CH-223191) treatment (upper panel) or Ahr knockdown (KD) (lower panel) for 4 and 8 h. Data are presented as mean ± standard deviation values ( n = 3; * p < 0.05, ** p < 0.01, *** p < 0.001; * compared with the control. # p < 0.05, ## p < 0.01, ### p < 0.001; # compared with the IS-treated group; Student t -test ( A , B ) and analysis of variance ( C )).

Article Snippet: The membrane was blocked with 5% skim milk–Tris-buffered saline with 0.1% Tween 20 for 1 h. After washing, the membrane was incubated overnight at 4 °C with primary antibodies against Runx2 (Abcam, Cambridge, UK, Cat# ab23981), Bmp2 (Abcam, Cat# ab14933), Alp (Abcam, Cat# ab203106), Oc (Abcam, Cat# ab93876), AhR (Santa Cruz Biotechnology, Inc., Dallas, TX, USA, Cat# sc-133088), Hes1 (NOVUS Biologicals, Centennial, CO, USA, Cat# NBP1-47791), and cleaved-Notch1 (Elabscience Biotechnology Co., Ltd., Wuhan, China, Cat# E-AB-30054).

Techniques: Expressing, Quantitative RT-PCR, Western Blot, Control, Knockdown, Standard Deviation

Journal: Cancer Research

Article Title: Aberrant Activation of Notch Signaling in Human Breast Cancer

doi: 10.1158/0008-5472.can-05-3054

Figure Lengend Snippet: Figure 1. Expression of Notch receptors and DSL ligands in the normal human breast. A-C, expression of Notch1 and Notch3 (lanes A2 and A4), Delta-like 4 (lane B4), and Jagged1 and Jagged2 (lanes C2 and C3) was detected in normal human breast tissue by reverse transcription-PCR (+RT, top). In contrast, primers specific to Notch2 (lane A3), Notch4 (lane A5), Delta-like 1 (lane B2), and Delta-like 3 (lane B3) genes failed to amplify a fragment, indicating that these genes were not expressed (+RT, top). Control reactions without reverse transcriptase were set up in parallel (RT, bottom). N, Notch; Dll, Delta-like; Jag, Jagged. D, immunolocalization of Notch receptors and DSL ligands identified by reverse transcription-PCR analysis of normal breast epithelial cell lines and tissue samples. Sections of normal human breast tissue were stained with antibodies that recognize Notch1, Notch3, Jagged1, and Jagged2. All four proteins were observed in the lobular epithelium and not in surrounding adipose tissue (arrows). Adjacent sections were stained without primary anti-Notch1, anti-Notch3, anti-Jagged1, and anti-Jagged2 antibodies as controls. Samples were counterstained with haemotoxylin to reveal morphology.

Article Snippet: Primary antibodies used were as follows: anti-cleaved Notch1 (Rockland), anti-Numb (Abcam, Cambridge, MA), anti-Noxa (Abcam), antiPuma (Novus Biologicals, Littleton, CO), anti-cleaved Caspase3 (Cell Signaling Technology, Beverly, MA), anti-Desmoplakin (kind gift of Prof. David Garrod, University of Manchester), anti-Hey1 (Santa Cruz Biotechnology), anti-E-cadherin (BD Biosciences, San Jose, CA), antitubulin (kind gift of Prof. Keith Gull, University of Oxford), anti–phosphoc-Jun NH2-terminal kinase (JNK) pT 183pY185 (Biosource, Camarillo, CA), anti–phopho-p53 pT81 (Cell Signaling Technology), anti-Keratin18 (NeoMarkers, Fremont, CA), anti-Actin (Sigma), and anti-focal adhesion kinase Cancer Res 2006; 66: (3).

Techniques: Expressing, Reverse Transcription, Control, Staining

Journal: Cancer Research

Article Title: Aberrant Activation of Notch Signaling in Human Breast Cancer

doi: 10.1158/0008-5472.can-05-3054

Figure Lengend Snippet: Figure 4. Notch signaling is elevated in human breast cancer cell lines and tissue samples. A, Western blot analysis of NICD, Numb, and Hey1 levels in three normal (lanes 1-3) and eight tumorigenic human breast epithelial cell lines (lanes 4-11). Numb expression was undetectable in all eight cancer cell lines tested, whereas NICD and Hey1 were up-regulated. The blot was stripped and reprobed with an antibody that recognizes actin to confirm equal loading. B, Western blot analysis of NICD and Numb levels in two normal and nine breast cancer tissue samples. Protein lysates from two normal tissue samples (lanes A and B) were separated by SDS-PAGE with either seven ER and PR expressing tumors (tumors C1-C7; Table 1), seven ER expressing tumors that lack PR (tumors D1-D7, Table 1), or six tumors that overexpress ErbB2 or EGFR (tumors E1-E3, F1, and G1 and G2). Representative examples from these blots are shown along with the two normal samples. As with the cancer cell lines, Numb was down-regulated in all breast cancer patients, whereas NICD was up-regulated. The blots were stripped and reprobed with an antibody that recognises epithelial marker Desmoplakin to confirm equal loading of the epithelial compartment. C, immunolocalisation of NICD, Numb, and Muc1 in a representative breast cancer tissue sample. Adjacent sections were stained with antibodies that recognise the NICD, Numb, and Muc1 (bottom). Down-regulation of Numb was accompanied by up-regulation of the active form of Notch in the epithelial cells as judged by Muc1 expression. Adjacent sections were stained without primary anti-Notch1, anti-Numb, and anti-Muc1 antibodies as controls (top). Samples were counterstained with hematoxylin to reveal morphology.

Article Snippet: Primary antibodies used were as follows: anti-cleaved Notch1 (Rockland), anti-Numb (Abcam, Cambridge, MA), anti-Noxa (Abcam), antiPuma (Novus Biologicals, Littleton, CO), anti-cleaved Caspase3 (Cell Signaling Technology, Beverly, MA), anti-Desmoplakin (kind gift of Prof. David Garrod, University of Manchester), anti-Hey1 (Santa Cruz Biotechnology), anti-E-cadherin (BD Biosciences, San Jose, CA), antitubulin (kind gift of Prof. Keith Gull, University of Oxford), anti–phosphoc-Jun NH2-terminal kinase (JNK) pT 183pY185 (Biosource, Camarillo, CA), anti–phopho-p53 pT81 (Cell Signaling Technology), anti-Keratin18 (NeoMarkers, Fremont, CA), anti-Actin (Sigma), and anti-focal adhesion kinase Cancer Res 2006; 66: (3).

Techniques: Western Blot, Expressing, SDS Page, Marker, Staining

Journal: Frontiers in Pharmacology

Article Title: Vitamin D/vitamin D receptor protects intestinal barrier against colitis by positively regulating Notch pathway

doi: 10.3389/fphar.2024.1421577

Figure Lengend Snippet: Inhibition of the Notch pathway aggravates DSS-induced colitis. CT: control, LY411,575 (Notch inhibitor): 10 mg/kg LY411,575 gavage, DSS: 2.5% DSS water, DSS-LY411,575: LY411,575 was intragastric administrated at the last 4 days of DSS feeding (once per day). (A) DAI scores of each group. DAI scores were compared by the repeated measures ANOVA with Bonferroni post hoc multiple comparisons. (B) Serum FD-4 concentration in each group. Statistical analysis was performed using ANOVA with Tukey’s post-test. (C) Histological scores of distal colons in each group. Statistical analysis was performed using ANOVA with Tukey’s post-test. (D) Representative colonic H&E staining image of each group (scale bar = 50 μm). (E) Representative colonic IF staining image of claudin-1 ( green ) and claudin-3 ( green ) (scale bar = 25 μm). (F) Representative colonic IF staining image and quantification of N1ICD ( red ) and Hes1 ( red ) (scale bar = 25 μm). Quantification of N1ICD and Hes1 were determined by the ratio of positive staining cells per crypt. Data are presented as the mean ± SEM from 6-8 mice in each study group. *: p < 0.05, **: p < 0.01, ***: p < 0.001.

Article Snippet: The sections were blocked in 5% goat serum (SL038; Solarbio) at 37°C for 1 h and were then incubated overnight with anti-claudin-1 (1:100; YT0942; Immunoway, TX, United States), anti-claudin-3 (1:100; 34–1700; Invitrogen, Shanghai, China), anti-cleaved Notch-1 (1:100; YC0067; N1ICD, Immunoway), and anti-Hes1 (1:200; GTX108356; GeneTex, Alton, IL, United States) antibodies in a humid environment at 4°C.

Techniques: Inhibition, Control, Concentration Assay, Staining

Journal: Frontiers in Pharmacology

Article Title: Vitamin D/vitamin D receptor protects intestinal barrier against colitis by positively regulating Notch pathway

doi: 10.3389/fphar.2024.1421577

Figure Lengend Snippet: Notch pathway is inhibited in the colon under VDd or VDR KO conditions. (A, B) Representative colonic IF staining image and quantification of N1ICD ( red ) and Hes1 ( red ) in VDR KO (A) and VDd (B) mice (scale bar = 25 μm). (C, D) Real-time PCR analysis of the gene expression of Notch ligands, receptors, and effectors in the colon in VDR KO (C) and VDd (D) mice. Expression levels (VDR KO vs. WT or VDd vs. CT) were compared using paired t -test. Data are presented as the mean ± SEM from 6-8 mice in each study group. *: p < 0.05, **: p < 0.01, ***: p < 0.001.

Article Snippet: The sections were blocked in 5% goat serum (SL038; Solarbio) at 37°C for 1 h and were then incubated overnight with anti-claudin-1 (1:100; YT0942; Immunoway, TX, United States), anti-claudin-3 (1:100; 34–1700; Invitrogen, Shanghai, China), anti-cleaved Notch-1 (1:100; YC0067; N1ICD, Immunoway), and anti-Hes1 (1:200; GTX108356; GeneTex, Alton, IL, United States) antibodies in a humid environment at 4°C.

Techniques: Staining, Real-time Polymerase Chain Reaction, Expressing

Journal: Frontiers in Pharmacology

Article Title: Vitamin D/vitamin D receptor protects intestinal barrier against colitis by positively regulating Notch pathway

doi: 10.3389/fphar.2024.1421577

Figure Lengend Snippet: VD/VDR modulates the Notch pathway in colitis. (A, B) Representative colonic IF staining image and quantification of N1ICD ( red ) and Hes1 ( red ) in VDd-DSS and respective control colitis mice (scale bar = 25 μm). (C, D) Representative colonic IF staining image and quantification of N1ICD ( red ) and Hes1 ( red ) in VDR KO-DSS and respective control colitis mice. To activate VDR, mice were administered paricalcitol (PAR) 7 days before drinking DSS water and were sustained until sacrifice. (E) DAI scores of each group. DAI scores were compared by the repeated measures ANOVA with Bonferroni post hoc multiple comparisons. (F) Histological scores of distal colons in each group. Statistical analysis was performed using ANOVA with Tukey’s post-test. (G) Representative colonic H&E staining image of each group (scale bar = 50 μm). (H) Representative colonic IF staining image of claudin-1 ( green ), claudin-3 ( green ), and Hes1 ( red ) (scale bar = 25 μm). Data are presented as the mean ± SEM from 6-8 mice in each study group. *: p < 0.05, **: p < 0.01, ***: p < 0.001.

Article Snippet: The sections were blocked in 5% goat serum (SL038; Solarbio) at 37°C for 1 h and were then incubated overnight with anti-claudin-1 (1:100; YT0942; Immunoway, TX, United States), anti-claudin-3 (1:100; 34–1700; Invitrogen, Shanghai, China), anti-cleaved Notch-1 (1:100; YC0067; N1ICD, Immunoway), and anti-Hes1 (1:200; GTX108356; GeneTex, Alton, IL, United States) antibodies in a humid environment at 4°C.

Techniques: Staining, Control

Journal: Frontiers in Pharmacology

Article Title: Vitamin D/vitamin D receptor protects intestinal barrier against colitis by positively regulating Notch pathway

doi: 10.3389/fphar.2024.1421577

Figure Lengend Snippet: VD/VDR signaling regulates the Notch pathway and TJs in Caco-2 cells. TNF-α (100 ng/mL) was added to mimic inflammatory stimulation, and 100 nM PAR was used to activate VDR; the solvate was added as control (CT). Specific siRNA of VDR (SiVDR) was used to downregulate VDR, negative control (NC) sequence was used as control (scale bar = 10 μm). (A) Representative IF staining image of claudin-1 ( green ) and claudin-3 ( green ) in Caco-2 cells treated with or without PAR before TNF-α intervention. (B) Representative IF staining image of N1ICD ( red ) and Hes1 ( red ) in Caco-2 cells with or without VDR downregulation before TNF-α intervention. (C) Representative IF staining image of claudin-1 ( green ), claudin-3 ( green ), N1ICD ( red ), and Hes1 ( red ) in Caco-2 cells after VDR downregulation.

Article Snippet: The sections were blocked in 5% goat serum (SL038; Solarbio) at 37°C for 1 h and were then incubated overnight with anti-claudin-1 (1:100; YT0942; Immunoway, TX, United States), anti-claudin-3 (1:100; 34–1700; Invitrogen, Shanghai, China), anti-cleaved Notch-1 (1:100; YC0067; N1ICD, Immunoway), and anti-Hes1 (1:200; GTX108356; GeneTex, Alton, IL, United States) antibodies in a humid environment at 4°C.

Techniques: Control, Negative Control, Sequencing, Staining

Journal: Frontiers in Pharmacology

Article Title: Vitamin D/vitamin D receptor protects intestinal barrier against colitis by positively regulating Notch pathway

doi: 10.3389/fphar.2024.1421577

Figure Lengend Snippet: VD/VDR-mediated TJ protection is partly dependent on the Notch pathway. LY411,575 (1 μM) was used to inhibit the Notch pathway in Caco-2 cells, and 100 nM PAR was used to activate VDR. The solvate was added as control (CT). Representative IF staining image of N1ICD ( red ), Hes1 ( red ), claudin-1 ( green ), and claudin-3 ( green ) in Caco-2 cells treated with or without LY411,575 before PAR intervention (scale bar = 10 μm).

Article Snippet: The sections were blocked in 5% goat serum (SL038; Solarbio) at 37°C for 1 h and were then incubated overnight with anti-claudin-1 (1:100; YT0942; Immunoway, TX, United States), anti-claudin-3 (1:100; 34–1700; Invitrogen, Shanghai, China), anti-cleaved Notch-1 (1:100; YC0067; N1ICD, Immunoway), and anti-Hes1 (1:200; GTX108356; GeneTex, Alton, IL, United States) antibodies in a humid environment at 4°C.

Techniques: Control, Staining

Journal: Frontiers in Pharmacology

Article Title: Vitamin D/vitamin D receptor protects intestinal barrier against colitis by positively regulating Notch pathway

doi: 10.3389/fphar.2024.1421577

Figure Lengend Snippet: VD/VDR signaling positively regulates the Notch-1/Hes1 pathway. (A) Representative IF staining image of claudin-1 ( green ), claudin-3 ( green ), N1ICD ( red ), and Hes1 ( red ) in cultured intestinal organoids (scale bar = 10 μm). (B) Western blot analysis of N1ICD and Hes1 proteins in cultured intestinal organoids from WT and VDR KO mice. (C) Real-time PCR analysis of the expression of Notch ligands, receptors, and Hes1 in cultured intestinal organoids from WT and VDR KO mice. (D) Real-time PCR analysis of the expression of Notch ligands, receptors, and Hes1 in Caco-2 cells after TNF-α intervention. (E, F) Real-time PCR analysis of the expression of Notch ligands, receptors, and Hes1 in Caco-2 cells after downregulation of VDR with siVDR (E) or activation of VDR with PAR (F) . Data are presented as the mean ± SEM from three separate experiments, the statistical analysis performed with paired t -test. *: p < 0.05, **: p < 0.01, ***: p < 0.001.

Article Snippet: The sections were blocked in 5% goat serum (SL038; Solarbio) at 37°C for 1 h and were then incubated overnight with anti-claudin-1 (1:100; YT0942; Immunoway, TX, United States), anti-claudin-3 (1:100; 34–1700; Invitrogen, Shanghai, China), anti-cleaved Notch-1 (1:100; YC0067; N1ICD, Immunoway), and anti-Hes1 (1:200; GTX108356; GeneTex, Alton, IL, United States) antibodies in a humid environment at 4°C.

Techniques: Staining, Cell Culture, Western Blot, Real-time Polymerase Chain Reaction, Expressing, Activation Assay

Journal: Frontiers in Pharmacology

Article Title: Vitamin D/vitamin D receptor protects intestinal barrier against colitis by positively regulating Notch pathway

doi: 10.3389/fphar.2024.1421577

Figure Lengend Snippet: VD/VDR positively regulates Notch-1 transcription. (A) Western blot analysis of VDR, Notch-1, N1ICD, and Hes1 in Caco-2 cells after siVDR and PAR intervention. (B) Graphs of the predicted VDR binding region in the Notch-1 promoter. (C) Dual-luciferase reporter assay of VDR to Notch-1 promoter. Notch-1 promoter (Notch-1) and negative control (CON) were constructed in a GV238 vector. The VDR cDNA and vector (pcDNA3.1) were linked to upregulate VDR (pVDR). Data are presented as the mean ± SEM from three separate experiments. Statistical analysis was performed using ANOVA with Tukey’s post-test. *: p < 0.05, **: p < 0.01, ***: p < 0.001.

Article Snippet: The sections were blocked in 5% goat serum (SL038; Solarbio) at 37°C for 1 h and were then incubated overnight with anti-claudin-1 (1:100; YT0942; Immunoway, TX, United States), anti-claudin-3 (1:100; 34–1700; Invitrogen, Shanghai, China), anti-cleaved Notch-1 (1:100; YC0067; N1ICD, Immunoway), and anti-Hes1 (1:200; GTX108356; GeneTex, Alton, IL, United States) antibodies in a humid environment at 4°C.

Techniques: Western Blot, Binding Assay, Luciferase, Reporter Assay, Negative Control, Construct, Plasmid Preparation